Fibrosis is the buildup of scar tissue in an organ or tissue, replacing normal healthy cells with stiff, fibrous material that doesn’t function the way the original tissue did. It can happen in nearly any organ, including the liver, lungs, heart, kidneys, and skin. Fibrotic diseases contribute to an estimated 45% of all deaths in industrialized countries, making this process one of the most significant and underrecognized drivers of chronic illness.
How Fibrosis Develops
Your body creates scar tissue as part of normal wound healing. When you cut your skin, specialized cells rush to the site, lay down structural proteins like collagen, and close the wound. In a healthy scenario, this repair process switches off once the job is done. Fibrosis happens when the process doesn’t shut down. Instead of healing and stopping, the body keeps producing scar tissue, gradually replacing functional organ tissue with dense, stiff material.
The key players in this process are cells called myofibroblasts. These are essentially repair cells stuck in overdrive. Normally dormant connective tissue cells get activated by chemical signals (particularly one called TGF-beta) and transform into myofibroblasts, which pump out large amounts of structural proteins. In fibrosis, these cells keep producing collagen and other matrix proteins long after the initial injury has resolved. The result is a buildup of tough, fibrous scaffolding that crowds out the organ’s working cells and makes the tissue progressively stiffer.
This can be triggered by chronic infection, autoimmune inflammation, toxins like alcohol, radiation, or repeated physical injury. Sometimes no clear cause is identified at all.
Where Fibrosis Occurs
Liver
Liver fibrosis is one of the most common forms and develops from ongoing damage caused by hepatitis B or C, heavy alcohol use, or fatty liver disease. Doctors grade it on a five-point scale: F0 is a normal liver, F1 means scarring limited to the areas around blood vessels, F2 involves scarring that has started bridging between those areas, F3 means widespread scarring, and F4 is cirrhosis, where the entire architecture of the liver is distorted by scar tissue. Each stage represents progressively worse disruption to the liver’s ability to filter blood, process nutrients, and clear toxins.
Lungs
Pulmonary fibrosis stiffens the thin, flexible walls of the air sacs where oxygen enters your blood. As scar tissue thickens these walls, less oxygen gets through with each breath. The most serious form, idiopathic pulmonary fibrosis (IPF), has no identifiable cause. On imaging, advanced lung fibrosis shows a distinctive “honeycombing” pattern: clusters of small cysts, typically 3 to 10 millimeters across, concentrated in the lower portions of the lungs. This pattern reflects the permanent destruction of normal lung tissue.
Heart
Cardiac fibrosis involves excessive collagen deposited between heart muscle cells. This stiffens the heart wall, which creates two major problems. First, the heart can’t relax properly between beats, so it fills with less blood (a condition called diastolic dysfunction). Second, scar tissue disrupts the electrical signals that coordinate heartbeats, increasing the risk of abnormal heart rhythms. Over time, cardiac fibrosis is a major contributor to heart failure.
Skin
Skin fibrosis is a hallmark of scleroderma, a condition where the skin becomes hard, tight, and shiny. It typically starts in the fingers, hands, feet, and face, sometimes spreading to the arms, chest, and legs. Early signs include swelling and itchiness. As fibrosis progresses, the skin may lighten or darken in patches, small red spots can appear on the hands and face, and calcium deposits may form under the skin at the fingertips.
Fibrosis Is Not Cystic Fibrosis
The term “fibrosis” sometimes gets confused with cystic fibrosis, but these are very different things. Cystic fibrosis is a genetic disease present from birth that causes thick, sticky mucus to build up in the lungs, pancreas, and other organs. It got its name because it causes cysts and scarring (fibrosis) specifically in the pancreas. General fibrosis, by contrast, is not a single disease. It’s a scarring process that can develop in any organ for many different reasons.
How Fibrosis Is Detected
For liver fibrosis, one of the most common non-invasive tools is a specialized ultrasound device that measures how stiff the liver tissue has become. Stiffness is reported in kilopascals (kPa), and the numbers correspond fairly directly to fibrosis stage. A reading around 7.2 kPa suggests at least moderate fibrosis. At 12.5 kPa, severe fibrosis is likely. A reading of 17.6 kPa or above points toward cirrhosis. Higher readings correlate with complications: values above 37.5 kPa suggest more advanced liver failure, and readings above 50 kPa are associated with serious complications like fluid buildup in the abdomen or liver cancer.
For lung fibrosis, high-resolution CT scans are the primary diagnostic tool. Radiologists look for patterns of scarring, honeycombing, and distorted airways, particularly in the lower and outer portions of the lungs. Heart fibrosis is typically identified through cardiac MRI, which can distinguish scar tissue from healthy muscle.
Can Fibrosis Be Reversed?
For a long time, fibrosis was considered permanent. That view has changed. Animal studies have shown that fibrotic tissue in the liver can be remodeled and near-normal organ structure restored once the source of injury is removed. More importantly, clinical data in humans now supports the same conclusion: patients whose underlying liver disease is effectively treated (for example, clearing a hepatitis C infection or stopping alcohol use) can experience genuine regression of fibrosis. The earlier the stage, the more reversible it tends to be. Advanced cirrhosis is far harder to undo, though even some cirrhotic patients show measurable improvement.
Lung fibrosis is generally less reversible. Two medications approved in 2014 for idiopathic pulmonary fibrosis slow the rate of lung function decline. Both work in part by interfering with the chemical signals that activate scar-producing cells, and both have been shown to inhibit the formation of collagen fibers directly, reducing the size and number of collagen bundles in lung tissue. These drugs don’t cure pulmonary fibrosis, but they can meaningfully slow its progression.
Cardiac fibrosis treatment focuses primarily on managing the underlying cause, whether that’s high blood pressure, a prior heart attack, or inflammatory heart disease. Controlling the source of injury can prevent further scarring, though reversing existing cardiac fibrosis remains difficult.
What Determines How Serious It Is
The impact of fibrosis depends on three things: which organ is affected, how much tissue has been replaced, and whether the underlying cause can be treated. A small amount of liver fibrosis from a now-resolved infection may never cause symptoms. Widespread lung fibrosis that continues progressing can be life-threatening. The same scarring process plays out differently depending on context.
Because fibrosis often develops silently over years or decades, it’s frequently discovered at a stage where significant tissue has already been replaced. This is part of why screening tools like liver stiffness measurements matter: they can catch the process before symptoms appear, when interventions are most effective and reversal is most likely.